Shionogi Inc.
Records under this name other than the patents Shionogi Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 12 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,740,219 | Analysis Method of 3-Methyl-1-Phenyl-2-Pyrazolin-5-ONE Active Pharmaceutical Ingredient, Treatment for Amyotrophic Lateral Sclerosis, Inhibition of Progression of Amyotrophic Lateral Sclerosis, and Method of Producing Medicament Containing 3-Methyl-1-Phenyl-2-Pyrazolin-5-ONE Active Pharmaceutical Ingredient Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 12,320,793 | Analysis Method of 3-Methyl-1-Phenyl-2-Pyrazolin-5-ONE Active Pharmaceutical Ingredient, Treatment for Amyotrophic Lateral Sclerosis, Inhibition of Progression of Amyotrophic Lateral Sclerosis, and Method of Producing Medicament Containing 3-Methyl-1-Phenyl-2-Pyrazolin-5-ONE Active Pharmaceutical Ingredient Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 8,778,924 | Modified release amoxicillin products Lapsed on the fee record Ended Jul 15, 2026 · Medium confidence | Lapsed on the fee record | Ended Jul 15, 2026 | Medium confidence |
| US 8,758,820 | Robust pellet Lapsed on the fee record Ended Jun 24, 2026 · From the USPTO record | Lapsed on the fee record | Ended Jun 24, 2026 | From the USPTO record |
| US 8,715,727 | Tablet for pulsed delivery Lapsed on the fee record Ended May 6, 2026 · From the USPTO record | Lapsed on the fee record | Ended May 6, 2026 | From the USPTO record |
| US 8,460,710 | Antibiotic product, use and formulation thereof Lapsed on the fee record Ended Jun 11, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jun 11, 2025 | From the USPTO record |
| US 8,425,936 | Antibiotic product, use and formulation thereof Lapsed on the fee record Ended Apr 23, 2025 · From the USPTO record | Lapsed on the fee record | Ended Apr 23, 2025 | From the USPTO record |
| US 8,357,394 | Compositions and methods for improved efficacy of penicillin-type antibiotics Lapsed on the fee record Ended Jan 22, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jan 22, 2025 | From the USPTO record |
| US 8,313,775 | Antibiotic product, use and formulation thereof Lapsed on the fee record Ended Nov 20, 2024 · From the USPTO record | Lapsed on the fee record | Ended Nov 20, 2024 | From the USPTO record |
| US 8,313,776 | Antibiotic product, use and formulation thereof Lapsed on the fee record Ended Nov 20, 2024 · From the USPTO record | Lapsed on the fee record | Ended Nov 20, 2024 | From the USPTO record |